Although FAP-PET imaging has certain limitations (e.g., overlapped uptake between tumor and benign fibrotic lesions), its noninvasive nature provides a valuable tool for both identifying suitable candidates for FAP-RLT and monitoring therapeutic response. The gene discussed is FAP; the disease is neoplasm.